ArticleExperimental & molecular medicine2025
Ret finger protein deficiency attenuates adipogenesis in male mice with high fat diet-induced obesity.
Article in Experimental & molecular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ret finger protein (RFP, also known as TRIM27) is a multifunctional E3 ubiquitin ligase implicated in transcriptional regulation. While previously reported to repress myogenesis, its role in adipose tissue metabolism remains unclear. Here, using both global and adipocyte-specific RFP-knockout male mice subjected to high-fat diet feeding, we found that RFP deficiency markedly attenuated body weight gain, adipose tissue expansion and adipocyte hypertrophy, while improving glucose tolerance, insulin sensitivity and circulating lipid profiles. Indirect calorimetry demonstrated significantly increased whole-body energy expenditure, independent of food intake or physical activity. Consistent with these murine findings, RFP expression was elevated in omental adipose tissue from obese human subjects, underscoring the translational relevance. Mechanistic studies revealed that RFP physically interacts with PPAR-γ and enhances its transcriptional activity, thereby promoting expression of adipogenic target genes such as AP2 and adiponectin. Loss of RFP suppressed adipocyte differentiation both in vivo and in vitro. Collectively, our findings identify RFP as a positive regulator of adipogenesis and systemic metabolism via PPAR-γ activation. Genetic ablation of RFP confers resistance to high-fat diet-induced obesity, suggesting that targeting RFP may represent a potential therapeutic strategy for obesity and related metabolic disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.